Indian Market Outlook: Brokerages Eye Varun Beverages and Sun Pharma for 2026 Long-Term Gains
Leading brokerage firms are signaling optimism for a select group of Indian equities, with Varun Beverages [VBL] and Sun Pharmaceutical Industries [SUNPHARMA] highlighted for their potential to deliver 10-20% returns by 2026.
As the Indian economy continues its robust growth trajectory, investors are keenly searching for opportunities that promise sustained returns over the long term. Insights from various top brokerage firms suggest a focus on companies with strong fundamentals and clear growth catalysts, identifying specific stocks with the potential to offer attractive returns by 2026. Among these, Varun Beverages [VBL] and Sun Pharmaceutical Industries [SUNPHARMA] have frequently emerged in their "buy" recommendations.
Varun Beverages [VBL], a key player in India's beverage sector and a major franchisee for PepsiCo, is often cited for its resilient business model and expanding market reach. The company benefits from increasing consumption of packaged beverages, particularly in untapped rural and semi-urban markets, alongside consistent product innovation. Analysts see its strong distribution network and potential for margin improvement as key drivers for future growth, making it a favourable long-term investment candidate.
Similarly, Sun Pharmaceutical Industries [SUNPHARMA], India's largest pharmaceutical company, holds a prominent position in brokerage recommendations. The pharmaceutical sector is known for its defensive qualities and steady demand, and Sun Pharma's diversified product portfolio, robust R&D pipeline, and significant presence in both domestic and international markets underpin its long-term appeal. The company's focus on specialty products and strategic acquisitions further bolsters its growth prospects in the coming years.
According to collated analyses from these firms, investors looking at a horizon up to 2026 could potentially see returns in the range of 10-20% from such fundamentally strong companies. These recommendations underscore a broader strategy of investing in market leaders within sectors poised for structural growth. While specific target prices from individual brokerages were not detailed in the collated reports, the consensus points towards a positive outlook for these two scrips.
Investors are advised to conduct their own thorough research and consider their risk appetite before making any investment decisions, as market conditions can change.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Stock market investments are subject to market risks. Please consult your financial advisor before making any investment decisions. StockTips.in is not a SEBI-registered investment advisor.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Stock market investments are subject to market risks. Please consult your financial advisor before making any investment decisions. StockTips.in is not a SEBI-registered investment advisor.